Literature DB >> 23419281

Erythema nodosum in a patient undergoing vemurafenib therapy for metastatic melanoma.

Annette Degen, Bernward Völker, Alexander Kapp, Ralf Gutzmer.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2013        PMID： 23419281     DOI： 10.1684/ejd.2012.1915

Source DB:  PubMed          Journal:  Eur J Dermatol        ISSN： 1167-1122            Impact factor:   3.328


× No keyword cloud information.
  3 in total

Review 1.  Managing the skin toxicities from new melanoma drugs.

Authors:  John C Mavropoulos; Timothy S Wang
Journal:  Curr Treat Options Oncol       Date:  2014-06

2.  [Cutaneous side effects of anti-tumor therapy with BRAF and MEK inhibitors].

Authors:  R Gutzmer; J C Hassel; K C Kähler; C Loquai; R Mössner; S Ugurel; L Zimmer; Für Komitee Kutane Nebenwirkungen Ado der das Ado
Journal:  Hautarzt       Date:  2014-07       Impact factor: 0.751

3.  Clinicopathological Characteristics Related to Etiologies of Erythema Nodosum: A 10-Year Retrospective Study.

Authors:  Preeyachat Limtong; Poonkiat Suchonwanit; Kumutnart Chanprapaph; Suthinee Rutnin
Journal:  Clin Cosmet Investig Dermatol       Date:  2021-11-30
  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.